Insights

Recent Product Launches Par Pharmaceutical has recently launched generic versions of popular medications such as DUEXIS and ibuprofen-famotidine, indicating a focus on expanding its product portfolio and potentially opening new sales avenues for sales development representatives to explore.

Strategic Partnerships Partnerships with companies like Sucampo Pharmaceuticals and Indivior PLC show that Par Pharmaceutical is actively engaging in collaborative ventures, presenting opportunities for business development professionals to leverage these connections for further sales opportunities and market expansion.

Patent Infringement Challenges Past legal challenges related to patent infringement, such as the case with the drug Prepopik, highlight the competitive landscape in which Par Pharmaceutical operates. Understanding these legal aspects can help sales development representatives position the company's offerings effectively against competitors.

Equipment Asset Sale The recent sale of manufacturing and laboratory equipment by Par Pharmaceutical to Federal Equipment Company could indicate operational changes within the company. Sales development representatives may find opportunities by offering complementary solutions or services to address any potential gaps created by such transactions.

High-Quality Generic Products With a focus on delivering high-quality, cost-effective generic pharmaceutical products, Par Pharmaceutical is positioned to attract customers looking for affordable yet reliable medications. Sales development representatives can emphasize the quality and affordability of Par Pharmaceutical's offerings in their sales pitches.

Par Specialty Pharmaceuticals Tech Stack

Par Specialty Pharmaceuticals uses 8 technology products and services including AutoCAD, Hyperion, SAP, and more. Explore Par Specialty Pharmaceuticals's tech stack below.

  • AutoCAD
    Cad & Graphics
  • Hyperion
    Corporate Performance Management
  • SAP
    Customer Relationship Management
  • Microsoft Excel
    Editors
  • Microsoft PowerPoint
    Editors
  • JD Edwards
    Enterprise
  • Kronos
    Human Resource Management System
  • Microsoft
    Miscellaneous

Media & News

Par Specialty Pharmaceuticals's Email Address Formats

Par Specialty Pharmaceuticals uses at least 1 format(s):
Par Specialty Pharmaceuticals Email FormatsExamplePercentage
First.Last@parpharm.comJohn.Doe@parpharm.com
65%
L.First@parpharm.comD.John@parpharm.com
25%
FLast@parpharm.comJDoe@parpharm.com
8%
First.L@parpharm.comJohn.D@parpharm.com
2%

Frequently Asked Questions

Where is Par Specialty Pharmaceuticals's headquarters located?

Minus sign iconPlus sign icon
Par Specialty Pharmaceuticals's main headquarters is located at 1 Ram Ridge Road Chestnut Ridge, NY 10977 US. The company has employees across 6 continents, including North AmericaAsiaEurope.

What is Par Specialty Pharmaceuticals's stock symbol?

Minus sign iconPlus sign icon
Par Specialty Pharmaceuticals is a publicly traded company; the company's stock symbol is PRX.

What is Par Specialty Pharmaceuticals's official website and social media links?

Minus sign iconPlus sign icon
Par Specialty Pharmaceuticals's official website is parpharm.com and has social profiles on LinkedIn.

How much revenue does Par Specialty Pharmaceuticals generate?

Minus sign iconPlus sign icon
As of June 2025, Par Specialty Pharmaceuticals's annual revenue reached $935M.

What is Par Specialty Pharmaceuticals's SIC code NAICS code?

Minus sign iconPlus sign icon
Par Specialty Pharmaceuticals's SIC code is 2834 - Pharmaceutical Preparations NAICS code is 325412 - Pharmaceutical Preparation Manufacturing.

How many employees does Par Specialty Pharmaceuticals have currently?

Minus sign iconPlus sign icon
As of June 2025, Par Specialty Pharmaceuticals has approximately 1.4K employees across 6 continents, including North AmericaAsiaEurope. Key team members include Chief Executive Officer: J. E.Chief Executive Officer: M. M.Chief Executive Officer: T. C.. Explore Par Specialty Pharmaceuticals's employee directory with LeadIQ.

What industry does Par Specialty Pharmaceuticals belong to?

Minus sign iconPlus sign icon
Par Specialty Pharmaceuticals operates in the Pharmaceutical Manufacturing industry.

What technology does Par Specialty Pharmaceuticals use?

Minus sign iconPlus sign icon
Par Specialty Pharmaceuticals's tech stack includes AutoCADHyperionSAPMicrosoft ExcelMicrosoft PowerPointJD EdwardsKronosMicrosoft.

What is Par Specialty Pharmaceuticals's email format?

Minus sign iconPlus sign icon
Par Specialty Pharmaceuticals's email format typically follows the pattern of . Find more Par Specialty Pharmaceuticals email formats with LeadIQ.

When was Par Specialty Pharmaceuticals founded?

Minus sign iconPlus sign icon
Par Specialty Pharmaceuticals was founded in 1978.
Par Specialty Pharmaceuticals

Par Specialty Pharmaceuticals

Pharmaceutical ManufacturingNew York, United States1001-5000 Employees

Par Pharmaceutical: High-Quality, Cost-Effective Generic Products

Par Pharmaceutical, headquartered in Chestnut Ridge, New York, develops, manufactures and markets safe, innovative and cost-effective generic pharmaceutical and branded injectable products that help improve patient quality of life. Par, among the top leaders in the U.S. generics industry, possesses a portfolio that includes sterile injectables, alternative dosage forms and many other differentiated products. Par is advancing a robust research and development (R&D) pipeline of potential products.  Par is an operating company of Endo International plc, a highly focused generics and specialty branded pharmaceutical company delivering quality medicines to patients through excellence in development, manufacturing and commercialization.

Section iconCompany Overview

Headquarters
1 Ram Ridge Road Chestnut Ridge, NY 10977 US
SIC Code
2834 - Pharmaceutical Preparations
Stock Symbol
PRX
NAICS Code
325412 - Pharmaceutical Preparation Manufacturing
Founded
1978
Employees
1001-5000

Section iconFunding & Financials

  • $100M$1B

    Par Specialty Pharmaceuticals's revenue is in the range of $100M$1B

Section iconFunding & Financials

  • $100M$1B

    Par Specialty Pharmaceuticals's revenue is in the range of $100M$1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.